The RDA COVID-19 Working Group was set up in March 2020. Its members, over 600, brought forward various global expertise to develop a body of work that comprises how data from multiple disciplines inform response to a pandemic, combined with guidelines and recommendations on data sharing under the present COVID-19 circumstances. The focus on data sharing includes all relevant research outputs, including the key role of research software in analysing data.
The work has been divided into four research areas (namely: Clinical, Omics, Epidemiology, Social Sciences) with four cross cutting themes (namely, Community Participation, Indigenous Data, Legal and Ethical Considerations, Research Software), as a way to focus the conversations, and provide an initial set of guidelines in a tight timeframe. The detailed guidelines are aimed to help stakeholders follow best practices to maximise the efficiency of their work, and to act as a blueprint for future emergencies. The recommendations in the document are aimed at helping policymakers and funders to maximise timely, quality data sharing and appropriate responses in such health emergencies.
The majority of the writing was executed in an intense period of just over 6 weeks, with five iterations, all of which were opened for public community comment. The final release with additional supporting outputs and links to previous releases are available at DOI: https://doi.org/10.15497/rda00052
This meeting will allow WG members to receive and update in what has happened since the Guiidelines were published, including new navigation tools, article outputs, as well as a discussion of intersections with other RDA groups, and what conmes next for the COVID-19 WG.